Chapter 1 Apoptosis as a gene-directed program of cell death

Principles of Medical Biology

Volumn 13, Issue C, 1998, Pages 1-55

  Alison, Malcolm R ^a   Sarraf, Catherine E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957021766     PISSN: 15692582     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2582(98)80003-2     Document Type: Article

References (123)

1. Alison M.R., and Sarraf C.E. Apoptosis: a gene-directed programme of cell death. J. Royal Coll. Phys. 26 (1992) 25-35
2. Alison M.R., and Sarraf C.E. Liver cell death: patterns and mechanisms. Gut 35 (1994) 577-581
3. Alison M.R., and Sarraf C.E. Apoptosis: regulation and relevance to toxicology. Human and Experimental Toxicology 14 (1995) 234-247
4. Alison M.R., and Sarraf C.E. Understanding cancer: from basic science to clinical practice (1997), Cambridge University Press, Cambridge
5. Alison M.R., Wilkins M.J.E., Walker S.M., and Hully J.R. Cell population size control in the rat liver: the response of hepatocytes in various proliferative states to a mitogenic stimulus. Epithelia 1 (1987) 53-64
6. Allen R.D., Marshall J.D., Roths J.B., and Sidman C.L. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 172 (1990) 1367-1375
7. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., and Yuan J. Human ICE/CED-3 protease nomenclature. Cell 87 (1996) 171
8. Amati B., Littlewood T.D., Evan G.I., and Land H. The c-myc protein induces cell cycle progression and apoptosis through dimerization with max. EMBO J. 12 (1993) 5083-5087
9. Ameisen J.C., Estaquier J., Idziorek T., and De Bels F. The relevance of apoptosis to AIDS pathogenesis. Trends in Cell Biology 5 (1995) 27-32
10. Anilkumar T.V., Sarraf C.E., Hunt T., and Alison M.R. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br. J. Cancer 65 (1992) 552-558
11. Arends M.J., Morris R.G., and Wyllie A.H. Apoptosis. The role of the endonuclease. Am. J. Pathol. 136 (1990) 593-608
12. Baker S.J., and Reddy E.P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12 (1996) 1-9
13. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., and Thompson C.V. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 (1993) 597-608
14. Boldin M.P., Goncharov T.M., Goltsev Y.V., and Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85 (1996) 803-815
15. Bortner C.D., Oldenburg N.B.E., and Cidlowski J.A. The role of DNA fragmentation in apoptosis. Trends in Cell Biol. 5 (1995) 21-27
16. Brancolini C., Benedetti M., and Schneider C. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like protease. EMBO J. 14 (1995) 5179-5190
17. Carrio R., Lopez-Hoyos M., Jimeno J., Benedict M.A., Merino R., Benito A., Fernandez-Luna J.L., Nunez G., Garcia-Porrero J.A., and Merino J. A1 demonstrates restricted tissue distribution during embryonic development and functions to protect against cell death. Am. J. Pathol. 149 (1996) 2133-2142
18. Casciola-Rosen L., Nicholson D.W., Chong T., Rowan K.R., Thornberry N.A., Miller D.K., and Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183 (1996) 1957-1964
19. Chinnaiyan A.M., and Dixit V.M. The cell death machine. Current Biology 6 (1996) 555-562
20. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271 (1996) 4573-4576
21. Chittenden T., Flemington C., Houghton A.B., Ebb R.G., Gallo G.J., Elangovan B., Chinnadurai G., and Lutz R.J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14 (1995) 5589-5596
22. Cohen J.J., and Duke R.C. Glucocorticoid activation of a calcium dependent endonuclease in thymic nuclei leads to cell death. J. Immunol. 132 (1984) 38-42
23. Darmon A.J., Nicholson D.W., and Bleackley R.C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377 (1995) 446-448
24. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
25. Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J., He W.-W., and Dixit V.M. ICE-LAP6, a novel nember of the ICE/Ced3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271 (1996) 16720-16724
26. Duke R.C., Chervenak R., and Cohen J.J. Endogenous endonuclease-induced DNA fragmentation: an early eventin cell-mediated cytolysis. Proc. Natl. Acad. Sci. USA 80 (1983) 6361-6365
27. Duvall E., Wyllie A.H., and Morris R.G. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 56 (1985) 351-358
28. Earnshaw W.C. Nuclear change in apoptosis. Curr. Opin. Cell Biol. 7 (1995) 337-343
29. Ellis H.M., and Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell 44 (1986) 817-829
30. Enari M., Hase A., and Nagata S. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14 (1995) 5201-5208
31. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., and Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 (1992) 119-129
32. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., and Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992) 2207-2216
33. Feinstein E., Kimchi A., Wallach D., Boldin M., and Varfolomeev E. The death domain: a module shared by proteins with diverse cellular functions. TIBS 20 (1995) 342-344
34. Fesus L. Biochemical events in naturally occurring forms of cell death. FEBS 328 (1993) 1-5
35. Filipski J., Leblanc J., Youdale T., Sikorska M., and Walker P.R. Periodicity of DNA folding in higher order chromatin structures. EMBO J. 9 (1990) 1319-1327
36. Finkel T.H., Tudor-Williams G., Banda N.K., Cotton M.F., Curiel T., Monks C., Baba T.W., Ruprecht R.M., and Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Medicine 1 (1995) 129-134
37. French L.E., Hahne M., Viard I., Radlgruber G., Zanone R., Becker K., Muller C., and Tschopp J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133 (1996) 335-343
38. Gagliardini V., Fernandez P.-A., Lee R.K.K., Drexler H.C.A., Rotello R.J., Fishman M.C., and Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science 263 (1994) 826-828
39. Gajewski T.F., and Thompson C.B. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87 (1996) 589-592
40. Golstein P., Marguet D., and Depraetere V. Fas bridging cell death and cytotoxicity: the reaper connection. Immunol. Revs. 146 (1995) 45-56
41. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., and Giacci A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
42. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E.A., Longthorne V.L., Culhane A.C., and Williams G.T. Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236 (1996) 1-26
43. Harley C.B., Kim N.W., Prowse K.R., Weinrich S.L., Hirsch K.S., West M.D., Bacchetti S., Hirte H.W., Counter C.M., Greider C.W., Piatyszek M.A., Wright W.E., and Shay J.W. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp. Quant. Biol. 59 (1994) 307-315
44. Hengartner M.O., and Horvitz H.R. Activation of C. elegans cell death protein CED-9 by an amino acid substitution in a domain conserved in Bcl-2. Nature 369 (1994)
45. Hengartner M.O., Ellis R.E., and Horvitz H.R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356 (1992) 494-499
46. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
47. Jacobson M.D., Burne J.F., and Raff M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13 (1994) 1899-1910
48. Jacobson M.D., Weil M., and Raff M.C. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133 (1996) 1041-1051
49. Jacobson M.D., Weil M., and Raff M.C. Programmed cell death in animal development. Cell 88 (1997) 347-354
50. Janicke R.U., Walker P.A., Lin X.Y., and Porter A.G. Specific cleavage of the retinoblastoma protein by ICE-like protease in apoptosis. EMBO J. 15 (1996) 6969-6978
51. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: a basis biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 68 (1972) 239-257
52. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes & Development 10 (1996) 1054-1072
53. Lacronique V., Mignon A., Fabre M., Viollet B., Rouquet N., Molina T., Porteu A., Henrion A., Bouscary D., Varlet P., Joulin V., and Kahn A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Medicine 2 (1996) 80-86
54. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
55. Lindahl T., Satoh M.S., Poirier G.G., and Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. TIBS 20 (1995) 405-411
56. Liu X., Kim C.N., Pohl J., and Wang X. Purification and characterization of an interleukin-1β-converting enzyme family protease that activates cysteine protease P32 (CPP32). J. Biol. Chem. 271 (1996) 13371-13376
57. Liu Y.-J., Joshua D.E., Williams G.T., Smith C.A., Gordon J., and MacLennan I.C.M. Mechanism of antigen-driven selection in germinal centres. Nature 342 (1989) 929-931
58. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., and Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 (1993) 847-849
59. Martin S.J., Amarante-Mendes G.P., Shi L., Chuang T.-H., Casiano C.A., O'Brien G.A., Fitzgerald P., Tan E.M., Bokoch G.M., Greenberg A.H., and Green D.R. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED3 family protease, CPP32, via a novel two step mechanism. EMBO J. 15 (1996) 2407-2416
60. Martin S.J., Newmeyer D.D., Mathias S., Farschon D.M., Wang H.-G., Reed J.C., Kolesnick R.N., and Green D.R. Cell-free reconstitution of Fas-, UV radiation- and ceramide induced apoptosis. EMBO J. 14 (1995) 5191-5200
61. Martin S.J., Reutelingsperger C.P.M., McGahon A.J., Rader J.A., van Schie R.C.A.A., LaFace D.M., and Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182 (1995) 1545-1556
62. McConkey D.J., Hartzell P., and Orrenius S. Rapid turnover of endogenous endonuclease activity in thymocytes: effects of inhibitors of macromolecular synthesis. Arch. Biochem. Biophys. 278 (1990) 284-287
63. McConkey D.J., Hartzell P., Nicotera P., and Orrenius S. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J. 3 (1989) 1843-1849
64. 2+ concentration. Arch. Biochem. Biophys. 269 (1989) 365-370
65. Merritt A.J., Potten C.S., Kemp C.J., Hickman J.A., Balmain A., Lane D.P., and Hall P.A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54 (1994) 614-617
66. L forms an ion channel in synthetic lipid membranes. Nature 385 (1997) 353-357
67. Miura M., Zhu H., Rotello R., Hartwieg E.A., and Yuan J. Induction of apopotosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C elegans cell death gene ced-3. Cell 75 (1993) 653-660
68. L, an, inhibitor of programmed cell death. Nature 381 (1996) 335-341
69. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rouke K.O., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., and Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3 like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85 (1996) 817-827
70. Na S., Chuang T.-H., Cunningham A., Turi T.G., Hanke J.H., Bokoch G.M., and Danley D.E. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem. 271 (1996) 11209-11213
71. Nagata S. Mutations in the Fas antigen in lpr mice. Immunology 6 (1994) 3-8
72. Nagata S. Apoptosis: telling cells their time is up. Current Biol. 6 (1996) 1241-1243
73. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
74. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Yu V.L., and Miller D.K. Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature 376 (1995) 37-43
75. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., Walker P.R., and Sikorska M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12 (1993) 3679-3684
76. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzwa A., Kasugai T., Kitamura Y., Itoh N., Suda T., and Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 364 (1993) 806-809
77. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74 (1993) 609-619
78. Patel T., Gores G.J., and Kaufmann S.H. The role of proteases during apoptosis. FASEB J 10 (1996) 587-597
79. Payne C.M., and Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leukemia and Lymphoma 19 (1995) 43-93
80. Peitsch M.C., Mannherz H.G., and Tschopp J. The apoptosis endonucleases: cleaning up after cell death?. Trends in Cell Biol. 4 (1994) 37-41
81. Rabizadeh S., LaCount D.J., Friesen P.D., and Bredesen D.E. Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J. Neurochem. 61 (1993) 2318-2321
82. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., and Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262 (1993) 695-700
83. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124 (1994) 1-6
84. Sanders E.J., and Wride M.A. Programmed cell death in development. Int. Rev. Cytol. 163 (1995) 105-173
85. Santana P., Pena L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchman E.H., Fuks Z., and Kolesnik R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86 (1996) 189-199
86. Sarraf C.E., and Bowen I.D. The occurrence of apoptosis in tumours and its effect on neoplastic development. In: Columbano A., Feo F., Pascale R., and Pani P. (Eds). Chemical Carcinogenesis 2. Modulating factors (1991), Plenum, New York 553-562
87. Sarraf C.E., Ansari T.W., Conway P., Notay M., Hill S., and Alison M.R. Bromodeoxyuridine-labelled apoptosis after treatment with antimetabolites in two murine tumours and small intestinal crypts. Br. J. Cancer 68 (1993) 678-680
88. Sarraf C.E., and Bowen I.D. Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br. J. Cancer 54 (1986) 989-998
89. Savill J.S., Dransfield I., Hogg N., and Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343 (1990) 170-173
90. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M., and Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads its recognition by macrophages. J. Clin. Invest. 83 (1989) 865-875
91. Schulze-Osthoff K., Walczak H., Droge W., and Krammer P.H. Cell nucleus and DNA fragmentation are not tequired for apoptosis. J. Cell Biol. 127 (1994) 15-20
92. Slee E.A., Zhu H., Chow S.C., MacFarlane M., Nicholson D.W., and Cohen G.M. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315 (1996) 21-24
93. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Litwack G., and Alnemri E.S. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93 (1996) 14486-14491
94. Strand S., Hofmann W.J., Hug H., Muller M., Otto G., Strand D., Mariani S.M., Stremmel W., Krammer P.H., and Galle P.R. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumour cells-a mechanism of immune evasion?. Nature Medicine 2 (1996) 1361-1370
95. Suda T., Takahashi T., Goldstein P., and Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumour necrosis family. Cell 75 (1993) 1169-1178
96. Thome M., Schneider P., Hofmann K., Fickenscher H., Meini E., Neipel F., Mattmann C., Burns K., Bodmer J.-L., Schroter M., Scaffidi C., Krammer P.H., Peter M.E., and Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386 (1997) 517-521
97. Trapani J.A., Browne K.A., Smyth M.J., and Jans D.A. Localization of granzyme B in the nucleus. J. Biol. Chem. 271 (1996) 4127-4133
98. Trauth B.C., Klas C., Peters A.M.J., Mazku S., Moller P., Falk W., Debatin K.-M., and Krammer P.H. Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science 245 (1989) 301-305
99. Vaux D.L. CED-4-the third horseman of apoptosis. Cell 90 (1997) 389-390
100. Vaux D., Cory S., and Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440-442
101. Vaux D.L., and Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93 (1996) 2239-2244
102. Veis D.J., Sorenson C.M., Shutter J.R., and Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75 (1993) 229-240
103. Venable M.E., Lee J.Y., Smyth M.J., Bielawska A., and Obeid L.M. Role of ceramide in cellular senescence. J. Biol. Chem. 270 (1995) 30701-30708
104. Wang H.-G., Takayama S., Rapp U.R., and Reed J.C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 93 (1996) 7063-7068
105. Wang X., Zelenski N.G., Yang J., Sakai J., Brown M.S., and Goldstein J.L. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15 (1996) 1012-1020
106. Wang X.W., Vermeulen W., Coursen J.D., Gibson M., Lupold S.E., Forrester K., Xu G., Elmore L., Yeh H., Hoeijmakers J.H.J., and Harris C.C. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes & Development 10 (1996) 1219-1232
107. Weil M., Jacobson M.D., Coles H.S.R., Davies T.J., Gardner R.L., Raff K.D., and Raff M.C. Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133 (1996) 1053-1059
108. White E. Life, death and the pursuit of apoptosis. Genes & Devel. 10 (1996) 1-15
109. White K., Tahaoglu E., and Steller H. Cell killing by the Drosophila gene reaper. Science 271 (1996) 805-811
110. Williams G.T. Apoptosis in the immune system. J. Path. 173 (1994) 1-4
111. Wyllie A.H., Kerr J.F.R., and Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68 (1980) 251-306
112. Yin C., Knudson C.M., Korsmeyer S.J., and Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis. Nature 385 (1997) 637-640
113. Yin X.M., Oltvai Z.N., and Kormeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369 (1994) 321-323
114. Yin X.M., Oltvai Z.N., Veis-Novack D.J., Linette G.P., and Korsmeyer S.J. Bcl-2 gene family and the regulation of programmed cell death. Cold Spring Harbor Symp. Quant. Biol. 59 (1994) 387-393
115. Yonehara S., Ishii A., and Yonehara M. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. J. Exp. Med. 169 (1989) 1747-1756
116. Yuan J., Shaham S., Ledoux S., Ellis H.M., and Horvitz H.R. The C.elegans cell death gene, ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75 (1993) 641-652
117. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., Remington L., Jacks T., and Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature 372 (1994) 773-776
118. Zha H., Aime-Sempe C., Sato T., and Reed J.C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271 (1996) 7440-7444
119. Zhivotovsky B., Wade D., Nicotera P., and Orrenius S. The role of nucleases in apoptosis. Int. Arch. Allergy Immunol. 105 (1994) 333-338
120. Zornig M., and Evan G.I. On target with Myc. Current Biology 6 (1996) 1553-1556
121. Enari M., Sakahira H., Yokoyama H., Ogawa K., Iwamatsu A., and Nagata S. A caspase-activated DNAse that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391 (1998) 43-50
122. Pan H., Yin C., and Van Dyke T. Apoptosis and cancer mechanisms. Cancer Survey 29 (1997) 305-327
123. Papa S., and Skulachev V.P. Reactive oxygen species, mitochondria, apoptosis, and aging. Mol. Cell Biochem. 174 (1997) 305-319